HIMSS: Health info exchange enables better stroke care

LAS VEGAS - The creation of a health information exchange in the Maryland/Washington,...Read more on AuntMinnie.comRelated Reading: eHealth Technologies signs Maryland HIE HIE cuts costs, but more savings may be possible Health information exchange cuts repeat imaging studies Report: HIE will drive new healthcare models HIMSS: RHIO image exchange saves lives, cuts dupe exams
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

A phase 2a study provides preliminary evidence that EDAS surgery to reroute brain arteries, used to treat moyamoya disease, may also reduce recurrent stroke in patients with intracranial stenosis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
A Chicago-based medical startup that wants to stop migraines using a nasal spray received more funding this week to continue its research. Seurat Therapeutics, a biotech startup founded within the University of Chicago, received a $500,000 grant from the National Institute of Neurological Disorders and Stroke. The funding will help the startup continue testing its product, a nasal spray that aims to stop the cause of migraines. The funding comes after the company raised $750,000 in seed funding…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
A new study says that smoking marijuana could raise the risk for any stroke by 15 percent and 29 percent for an ischemic stroke -- the most common kind,
Source: WebMD Health - Category: Consumer Health News Source Type: news
Date: Friday, 11 30, 2018; Speaker: Lawrence Corey, M.D., President and Director Emeritus , Fred Hutchinson Cancer Research Center; Patricia Flatley Brennan, R.N., Ph.D, Director , National Library of Medicine; Carl W. Dieffenbach, Ph.D., Director, Division of AIDS; Maureen M. Goodenow, Ph.D., Director, Office of AIDS Reseach ; Avindra Nath, M.D., Senior Investigator, National Institute of Neurological Disorders and Stroke; Daniel Appella, Ph.D., Senior Investigator, National Institute of Diabetes and Digestive and Kidney Diseases; Dima Hammoud, M.D., Investigator , NIH Clinical Center; Building: Building 38A (Lister Hill National Center)
Source: NIH Calendar of Events - Category: American Health Source Type: events
Abbott (NYSE:ABT) said today it won FDA approval for its HeartMate 3 left ventricular assist device, now approved as a destination therapy for patients with advanced heart failure. With the approval, the Chicago-based company said that the device can now be used in patients not eligible for a transplant as a life-long implant. “We partner with physicians to holistically develop therapies that benefit patients and achieve better outcomes. The unique design of the HeartMate 3 LVAD—with its Full MagLev technology—takes an established innovation and improves upon it in meaningful ways to help people with...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Abbott Source Type: news
Conditions:   Brain Ischemia;   Hemiplegic Patients With Stroke;   Image Science;   Electrophysiology of Neuromuscular;   Abdominal Acupuncture Interventions:   Other: Abdominal acupuncture;   Other: Sham abdominal acupuncture Sponsors:   Guangzhou University of Traditional Chinese Medicine;   Chinese University of Hong Kong Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Hypertension;   Stroke;   Blood Pressure, High;   Systolic Hypertension;   Transient Ischemic Attack;   Cerebrovascular Accident Intervention:   Combination Product: TEC4Home Stroke Cohort Sponsors:   Vancouver Coastal Health Research Institute;   VGH and UBC Hospital Foundation;   Vancouver General Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Rehabilitation, Tenodesis, Stroke Intervention:   Other: Motor task specific training Sponsor:   National Cheng-Kung University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Embolic Stroke of Undetermined Source Intervention:   Sponsors:   University of British Columbia;   Boehringer Ingelheim Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
PMID: 30328396 [PubMed - in process]
Source: Current Neuropharmacology - Category: Drugs & Pharmacology Authors: Tags: Curr Neuropharmacol Source Type: research
More News: Healthcare Information and Management Systems Soci | Stroke | Study